Radiofrequency Ablation in Treating Patients With Bone Metastases

OBJECTIVES: * Determine the side effects of radiofrequency ablation in patients with bone metastases. * Determine the effect of this regimen on pain in these patients. * Determine the effect of this regimen on mood in these patients. * Determine the effects of narcotic usage in patients treated with this regimen. * Determine the relationship between laboratory and imaging features of this treatment and the effects of the treatment in these patients. OUTLINE: This is a multicenter study. Patients undergo percutaneous CT-guided radiofrequency ablation directly to the metastatic lesion over approximately 12 minutes. Pain and mood are assessed at baseline, daily for 14 days after treatment, and at 1 and 3 months after treatment. Patients are followed at 1 week and then at 1 and 3 months. PROJECTED ACCRUAL: Approximately 75 patients will be accrued for this study within 12.5 months.